Sensata Technologies Holding plc shareholders approved Advisory resolution on frequency of "say-on-pay" at the 2026-06-09 meeting.
“This resolution was approved for every year.”
Results of shareholder votes disclosed under 8-K Item 5.07.
Sensata Technologies Holding plc shareholders approved Advisory resolution on frequency of "say-on-pay" at the 2026-06-09 meeting.
“This resolution was approved for every year.”
Sensata Technologies Holding plc shareholders approved Advisory resolution to approve the compensation of our named executive officers at the 2026-06-09 meeting.
“Absmeier 134,114,510 971,144 31,778 4,598,377 Daniel L. Black 133,521,952 1,563,542 31,938 4,598,377 Lorraine A. Bolsinger 131,398,259 3,688,295 30,878 4,598,377 Philip Eyler 134,055,499 1,030,625 31,308 4,598,377 Laurie Schupmann 134,113,847 958,010 45,575 4,598,377 Constance E.”
Sensata Technologies Holding plc shareholders approved Election of Directors at the 2026-06-09 meeting.
“Each of the nominees was elected for a term of one year.”
IMAX CORP shareholders approved Advisory vote on the compensation of the Company’s Named Executive Officers at the 2026-06-10 meeting.
“The shareholders approved the advisory vote on the compensation of the Company’s Named Executive Officers (the “NEOs”). Votes For Votes Against Votes Withheld/Abstained Broker Non-Votes 30,397,652 16,187,383 1,308,376 1,937,317”
IMAX CORP shareholders approved Appointment of PricewaterhouseCoopers LLP as independent auditors at the 2026-06-10 meeting.
“The shareholders approved the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditors until the next annual meeting of shareholders in 2027, and shareholders authorized the directors to fix the independent auditors’ remuneration. Votes For Votes Withheld/Abstained Broker Non-Votes 49,292,231 538,495 2”
IMAX CORP shareholders approved Election of Directors at the 2026-06-10 meeting.
“Election of Directors Gail Berman, Eric A. Demirian, Kevin Douglas, Richard L. Gelfond, David W. Leebron, Michael MacMillian, Steve Pamon, Dana Settle, Darren Throop, and Jennifer Wong were elected as directors of the Company.”
BeOne Medicines Ltd. shareholders approved Proposal to approve the maximum aggregate compensation of the Board of Directors under Swiss law for the applicable period at the 2026-06-11 meeting.
“Proposal to approve the maximum aggregate compensation of the Board of Directors under Swiss law for the applicable period: Votes For Votes Against Abstentions Broker Non-Votes 980,858,936 47,367,478 32,793,555 — Accordingly, the maximum aggregate compensation of the Board of Directors under Swiss law for the applicable period was approved.”
BeOne Medicines Ltd. shareholders approved Proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in the Proxy Statement, for fiscal year ended December 31, 2025 at the 2026-06-11 meeting.
“Proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in the Proxy Statement, for fiscal year ended December 31, 2025: Votes For Votes Against Abstentions Broker Non-Votes 975,327,100 52,877,460 32,815,949 — Accordingly, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in the Proxy Statement, was approved.”
BeOne Medicines Ltd. shareholders approved Proposal to authorize the Board of Directors to fix the auditors' compensation for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.
“Proposal to authorize the Board of Directors to fix the auditors' compensation for the fiscal year ending December 31, 2026: Votes For Votes Against Abstentions Broker Non-Votes 1,022,450,031 3,162,724 35,208,860 — Accordingly, the Board of Directors was authorized to fix the auditors' compensation for the fiscal year ending December 31, 2026.”
BeOne Medicines Ltd. shareholders approved Proposal to ratify the appointment of Ernst & Young LLP, Ernst & Young and Ernst & Young Hua Ming LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 and to re-elect Ernst & Young AG as the Company's statutory auditor for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.
“Proposal to ratify the appointment of Ernst & Young LLP, Ernst & Young and Ernst & Young Hua Ming LLP as the Company's independent auditors for the fiscal year ending December 31, 2026 and to re-elect Ernst & Young AG as the Company's statutory auditor for the fiscal year ending December 31, 2026: Votes For Votes Against Abstentions Broker Non-Votes 1,052,800,458 8,153,634 72,817 — Accordingly, the appointment of Ernst & Young LLP, Ernst & Young and Ernst & Young Hua Ming LLP as the Company's independent auditors was ratified and Ernst & Young AG was re-elected as the Company's statutory auditor.”
BeOne Medicines Ltd. shareholders approved Proposal to elect Schweiger Advokatur/Notariat as the Independent Voting Representative for a term extending until completion of the 2027 annual general meeting at the 2026-06-11 meeting.
“Proposal to elect Schweiger Advokatur/Notariat as the Independent Voting Representative for a term extending until completion of the 2027 annual general meeting: Votes For Votes Against Abstentions Broker Non-Votes 1,028,087,301 150,289 32,789,319 — Accordingly, Schweiger Advokatur/Notariat was elected as the Independent Voting Representative.”
BeOne Medicines Ltd. shareholders approved Proposal to re-elect Dr. Margaret Dugan and to elect Ms. Elizabeth F. Mooney to serve as a member of the Compensation Committee of the Board of Directors for a term extending until the 2027 annual general meeting at the 2026-06-11 meeting.
“Proposal to re-elect Dr. Margaret Dugan and to elect Ms. Elizabeth F. Mooney to serve as a member of the Compensation Committee of the Board of Directors for a term extending until the 2027 annual general meeting: Nominee Votes For Votes Against Abstentions Broker Non-Votes Dr. Margaret Dugan 1,012,836,634 15,408,489 32,781,786 — Ms. Elizabeth F. Mooney 1,028,055,025 172,249 32,799,635 — Accordingly, each of the nominees listed above was elected to serve as a member of the Compensation Committee of the Board of Directors.”
BeOne Medicines Ltd. shareholders approved Proposal to re-elect Mr. John V. Oyler as Chairman of the Board of Directors for a term extending until completion of the 2027 annual general meeting at the 2026-06-11 meeting.
“Proposal to re-elect Mr. John V. Oyler as Chairman of the Board of Directors for a term extending until completion of the 2027 annual general meeting: Votes For Votes Against Abstentions Broker Non-Votes 939,342,084 88,905,363 32,779,462 — Accordingly, Mr. John V. Oyler was re-elected to serve as Chairman of the Board of Directors.”
BeOne Medicines Ltd. shareholders approved Proposal to re-elect each of Dr. Olivier Brandicourt, Dr. Margaret Dugan, Mr. Anthony C. Hooper, Mr. John V. Oyler, Dr. Alessandro Riva, Ms. Shalini Sharp, and Dr. Xiaodong Wang, and to elect each of Dr. Felix J. Baker, Ms. Elizabeth F. Mooney and Dr. Charles L. Sawyers to serve as a director for a at the 2026-06-11 meeting.
“Proposal to re-elect each of Dr. Olivier Brandicourt, Dr. Margaret Dugan, Mr. Anthony C. Hooper, Mr. John V. Oyler, Dr. Alessandro Riva, Ms. Shalini Sharp, and Dr. Xiaodong Wang, and to elect each of Dr. Felix J. Baker, Ms. Elizabeth F. Mooney and Dr. Charles L. Sawyers to serve as a director for a term extending until completion of the 2027 annual general meeting: Nominee Votes For Votes Against Abstentions Broker Non-Votes Dr. Olivier Brandicourt 1,022,508,944 5,736,979 32,780,986 — Dr. Margaret Dugan 1,011,658,169 16,567,756 32,794,584 — Mr. Anthony C. Hooper 997,703,483 29,570,339 33,746,687 — Mr. John V. Oyler 1,013,945,040 12,727,593 34,347,876 — Dr. Alessandro Riva 708,200,626 320,024,909 32,794,974 — Ms. Shalini Sharp 998,811,368 28,636,943 33,572,198 — Dr. Xiaodong Wang 1,022,595,038 5,650,686 32,774,785 — Dr. Felix J. Baker 856,267,633 171,971,786 32,781,090 — Ms. Elizabeth F. Mooney 1,028,073,956 152,008 32,794,545 — Dr. Charles L. Sawyers 1,028,075,907 146,090 32,804,912 —”
BeOne Medicines Ltd. shareholders approved Proposal to discharge the members of the Board of Directors and the Executive Management Team from liability for activities during the applicable period under Swiss law at the 2026-06-11 meeting.
“Proposal to discharge the members of the Board of Directors and the Executive Management Team from liability for activities during the applicable period under Swiss law: Votes For Votes Against Abstentions Broker Non-Votes 816,696,880 2,683,088 177,864,348 — Accordingly, the members of the Board of Directors and the Executive Management Team were discharged from liability for such activities during the applicable period.”
BeOne Medicines Ltd. shareholders approved Proposal to approve the appropriation of the accumulated loss for fiscal year 2025 at the 2026-06-11 meeting.
“Proposal to approve the appropriation of the accumulated loss for fiscal year 2025: Votes For Votes Against Abstentions Broker Non-Votes 1,028,050,311 180,369 32,789,829 — Accordingly, the appropriation of the accumulated loss for fiscal year 2025 was approved.”
BeOne Medicines Ltd. shareholders approved Proposal to approve the audited Swiss statutory standalone financial statements and the audited Swiss statutory consolidated financial statements of the Company for fiscal year 2025 at the 2026-06-11 meeting.
“Proposal to approve the audited Swiss statutory standalone financial statements and the audited Swiss statutory consolidated financial statements of the Company for fiscal year 2025: Votes For Votes Against Abstentions Broker Non-Votes 1,026,904,777 175,000 33,940,732 — Accordingly, the audited Swiss statutory standalone financial statements and the audited Swiss statutory consolidated financial statements of the Company for fiscal year 2025 were approved.”
Alphatec Holdings, Inc. shareholders approved Non-binding advisory vote on the compensation of named executive officers at the 2026-06-10 meeting.
“The stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers by the following vote:”
Alphatec Holdings, Inc. shareholders approved Approval of Alphatec Holdings, Inc. 2026 Employee Stock Purchase Plan at the 2026-06-10 meeting.
“The stockholders approved the Alphatec Holdings, Inc. 2026 Employee Stock Purchase Plan by the following vote:”
Alphatec Holdings, Inc. shareholders approved Approval of Alphatec Holdings, Inc. 2026 Equity Incentive Plan at the 2026-06-10 meeting.
“The stockholders approved the Alphatec Holdings, Inc. 2026 Equity Incentive Plan by the following vote:”
Alphatec Holdings, Inc. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-10 meeting.
“The stockholders ratified the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2026 by the following vote:”
Alphatec Holdings, Inc. shareholders approved Election of seven directors to serve until the 2027 Annual Meeting at the 2026-06-10 meeting.
“The stockholders elected each of Mortimer Berkowitz III, Quentin Blackford, David Demski, Karen K. McGinnis, Patrick S. Miles, David R. Pelizzon, and Keith Valentine to serve on the Company’s Board of Directors for a term of one year until the 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified, or until their earlier death or resignation, by the following vote:”
NATURAL GAS SERVICES GROUP INC shareholders approved Approve the Redomestication of the Company From Colorado to Texas by Conversion at the 2026-06-10 meeting.
“The shareholders approved the redomestication of the Company from Colorado to Texas by conversion by the following vote: For Against Abstentions Broker Non-Votes 9,219,513 113,692 5,852 1,215,264”
NATURAL GAS SERVICES GROUP INC shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.
“The shareholders ratified the appointment of Ham, Langston & Brezina LLP as the Company’s independent registered public accounting firm for fiscal year 2026 by the following vote: For Against Abstentions 10,425,583 3,207 125,531”
NATURAL GAS SERVICES GROUP INC shareholders approved Election of Directors at the 2026-06-10 meeting.
“Each of the three nominees for director was duly elected by the Company’s shareholders, with votes as follows: Director Nominee For Against Abstentions/Withheld Broker Non-Votes 1A. J. Anthony Gallegos, Jr. (1) 9,012,307 321,253 5,497 1,215,264 1B. Justin C. Jacobs (1) 9,056,225 280,273 2,559 1,215,264 1C. John E. Jackson (1) 9,311,247 22,313 5,497 1,215,264”
Remitly Global, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.
“Proposal 3 — Ratification of Appointment of Independent Registered Public Accounting Firm The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, was approved based upon the following votes: For Against Abstain 153,679,087 7,056,245 131,795”
Remitly Global, Inc. shareholders approved Advisory Vote to Approve Executive Compensation at the 2026-06-10 meeting.
“Proposal 2 — Advisory Vote to Approve Executive Compensation The stockholders approved, on an advisory basis, the compensation of the Company's named executive officers. For Against Abstain Broker Non-Votes 135,017,111 5,226,478 98,493 20,525,045”
Remitly Global, Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.
“Proposal 1 — Election of Directors The following nominees were elected to the Company’s Board of Directors to hold office for terms to expire upon the annual stockholders’ meeting to be held in 2029 or until their successors are elected and qualified, or until their earlier death, resignation, or removal. The votes cast at the Annual Meeting were as follows: Nominee For Withheld Broker Non-Votes Bora Chung 134,764,920 5,577,162 20,525,045 Laurent Le Moal 135,211,923 5,130,159 20,525,045 Nigel Morris 96,695,642 43,646,440 20,525,045”
REED'S, INC. shareholders approved Non-Binding Advisory Vote on the Frequency of Stockholder Advisory Votes on the Compensation of the Company’s Named Executive Officers.
“5. Non-Binding Advisory Vote on the Frequency of Stockholder Advisory Votes on the Compensation of the Company’s Named Executive Officers One Year Two Years Three Years Abstentions Broker Non-Votes 176,660 4,300 6,893,600 269 1,035,603 The Company’s stockholders voted three years for the frequency of stockholder advisory votes on the compensation of the Company’s named executive officers.”
REED'S, INC. shareholders approved Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers.
“4. Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers For Against Abstentions Broker Non-Votes 7,068,913 5,756 160 1,035,603 The Company’s stockholders passed the advisory vote on the compensation of the Company’s named executive officers.”
REED'S, INC. shareholders approved Approval of the 2026 Equity Incentive Plan.
“3. Approval of the 2026 Equity Incentive Plan For Against Abstentions Broker Non-Votes 6,896,454 178,156 219 1,035,603 The Company’s stockholders approved the 2026 Plan.”
REED'S, INC. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2026-12-31 meeting.
“2. Ratification of Selection of Independent Registered Public Accounting Firm For Against Abstentions 8,099,074 10,794 564 The Company’s stockholders ratified the appointment of Weinberg & Company P.A. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”
REED'S, INC. shareholders approved Election of Directors.
“1. Election of Directors Name For Withhold Broker Non-Votes Shufen Deng 7,069,234 5,595 1,035,603 Neal M. Cohane 7,069,872 4,957 1,035,603 Michael C. Tu 7,069,534 5,295 1,035,603 Sam Van 7,069,370 5,459 1,035,603 Rudolf J. M. Bakker 7,069,373 5,456 1,035,603 Each of Shufen Deng, Neal M. Cohane, Michael C. Tu, Sam Van, and Rudolf J. M. Bakker were elected as directors”
Heritage Insurance Holdings, Inc. shareholders approved Approval, on Advisory Basis, of the Frequency of Future Advisory Votes on the Compensation of the Company’s Named Executive Officers at the 2026-06-10 meeting.
“The results of the vote to approve, on an advisory basis, the frequency of future advisory votes on the compensation of the Company’s named executive officers was as follows: ONE YEAR TWO YEARS THREE YEARS ABSTAIN BROKER NON- VOTES 15,365,458 91,456 1,888,824 243,109 5,508,690”
Heritage Insurance Holdings, Inc. shareholders approved Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers at the 2026-06-10 meeting.
“The results of the vote to approve, on an advisory basis, the compensation of the Company’s named executive officers was as follows: FOR AGAINST ABSTAIN BROKER NON- VOTES 16,268,417 1,049,362 271,068 5,508,690”
Heritage Insurance Holdings, Inc. shareholders approved Ratification of Appointment of Plante & Moran, PLLC to Serve as Independent Registered Public Accounting Firm at the 2026-06-10 meeting.
“The ratification of Plante & Moran, PLLC to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as follows: FOR AGAINST ABSTAIN 22,960,126 63,723 73,688”
Heritage Insurance Holdings, Inc. shareholders approved Election of Directors at the 2026-06-10 meeting.
“The following nominees were elected to the Board of Directors to serve until the 2027 annual meeting of stockholders, as follows: FOR WITHHELD BROKER NON- VOTES Panagiotis (Pete) Apostolou 14,587,912 3,000,935 5,508,690 Irini Barlas 16,311,396 1,277,451 5,508,690 Ernie Garateix 17,019,685 569,162 5,508,690 Joseph Vattamattam 17,311,716 277,131 5,508,690 Paul L. Whiting 16,699,466 889,381 5,508,690 Richard Widdicombe 16,460,212 1,128,635 5,508,690”
NWPX Infrastructure, Inc. shareholders approved Ratification of the appointment of Baker Tilly US, LLP as the Company's independent registered public accountants for the year ending December 31, 2026 at the 2026-06-10 meeting.
“Ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accountants for the year ending December 31, 2026: For Against Abstain Broker Non‐votes 8,572,555 48,781 8,696 -”
NWPX Infrastructure, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-10 meeting.
“Advisory vote on executive compensation: For Against Abstain Broker Non‐votes 7,315,387 163,194 79,105 1,072,346”
NWPX Infrastructure, Inc. shareholders approved Election of two directors at the 2026-06-10 meeting.
“Election of two directors: Nominee For Withheld Broker Non‐votes Scott Montross (three‐year term) 7,388,984 168,702 1,072,346 John Paschal (three-year term) 5,387,094 2,170,592 1,072,346”
Acushnet Holdings Corp. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-06-08 meeting.
“Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026.”
Acushnet Holdings Corp. shareholders approved Non-Binding Vote to Approve Executive Compensation at the 2026-06-08 meeting.
“Stockholders approved, in a non-binding advisory vote, the compensation of the Company’s named executive officers for fiscal year 2025.”
Acushnet Holdings Corp. shareholders approved Election of Directors at the 2026-06-08 meeting.
“Stockholders elected the director nominees listed below to serve as members of the Company’s Board of Directors.”
Fidelity National Financial, Inc. shareholders approved Ratify appointment of Ernst & Young LLP as independent registered public accounting firm for 2026 fiscal year.
“FOR AGAINST ABSTAIN 239,467,458 648,427 216,631”
Fidelity National Financial, Inc. shareholders approved Non-binding advisory resolution on compensation paid to our named executive officers.
“FOR AGAINST ABSTAIN BROKER NON-VOTES 203,983,950 10,025,836 365,856 25,956,874”
Fidelity National Financial, Inc. shareholders approved Approve Amended and Restated Articles of Incorporation to implement annual elections of directors.
“FOR AGAINST ABSTAIN BROKER NON-VOTES 213,953,766 253,201 168,675 25,956,874”
Fidelity National Financial, Inc. shareholders approved Elect four Class III directors to serve until the 2029 Annual Meeting of Stockholders.
“FOR WITHHELD BROKER NON-VOTES William P. Foley II 168,273,395 46,102,247 25,956,874 Douglas K. Ammerman 193,164,233 21,211,409 25,956,874 Thomas M. Hagerty 198,538,903 15,836,739 25,956,874 Peter O. Shea, Jr. 180,312,569 34,063,073 25,956,874”
Carlyle Secured Lending, Inc. shareholders approved To authorize the Company, with the approval of the Board of Directors, to sell or otherwise issue shares of common stock at a price below the then-current net asset value per share, subject to certain limitations, during the next 12 months at the 2026-06-09 meeting.
“Proposal 1. The authorization of the Company, with the approval of the Company’s Board of Directors, to sell or otherwise issue shares of the Company’s common stock, during the next 12 months following stockholder approval, at a price below the then-current net asset value per share, subject to certain limitations described in the proxy statement: For Against Abstain Broker Non-Votes 26,328,719 7,457,315 2,023,401 —”
QUALYS, INC. shareholders approved Approval of 2012 Equity Incentive Plan, as amended and restated at the 2026-06-10 meeting.
“The stockholders approved the Plan, as amended and restated.”
QUALYS, INC. shareholders approved Advisory Approval of Executive Compensation at the 2026-06-10 meeting.
“The stockholders cast their votes with respect to the advisory vote to approve the compensation of the Company’s named executive officers as described in the Company’s Proxy Statement, as follows:”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.